Bipolar Flashcards

1
Q

Bipolar I

A

One or more manic or mixed episodes

Most also have some depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Bipolar II

A

One or more depressive episodes + at least one hypomanic episode

Often misdiagnosed as MDD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cyclothymic disorder

A

Several periods of hypomania and mild depression but do not meet criteria for mania, major depressive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rapid cycling

A

At least 4 episodes of mania, hypomania, or depression in 1 year with 2 months between episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bipolar I treatment of choice

A

Lithium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lithium onset

A

Antimania: 1-2 weeks. May need adjunctive benzo or antipsychotic to control symptoms

Antidepressant effect: 6-8 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lithium monitoring labs

A

Baseline: CBC, electrolytes, renal function, thyroid function, UA, ECG, pregnancy test

every 6-12 months: Renal function, thyroid function, UA

Order serum concentration 12 hours after last dose, 5-6 days after initiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lithium serum concentration for acute mania

A

0.8-1.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lithium serum concentration for maintenance

A

0.6-1.0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lithium toxicity

A

Lethargy
Coarse tremor
Confusion
Seizures
Coma
Death

Treatment of choice if severe: hemodialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Intervention if rash, psoriasis from lithium

A

D/C drug (temporary or permanent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Intervention of tremor from lithium

A

Decrease dose
Add BB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Intervention if CNS toxicity from lithium

A

Reduce dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Intervention if GI upset from lithium

A

Reduce dose
Try ER
Split doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Intervention if hypothyroid from lithium

A

Levothyroxine
D/C lithium if necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Intervention if polydipsia or polyuria from lithium

A

Reduce dose
Manage fluid intake
Change to single bedtime dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Intervention if interstitial fibrosis or glomerulosclerosis from lithium

A

Lower dose to achieve lowest effective concentration

Avoid dehydration

18
Q

Lithium and pregnancy

A

Avoid during first trimester

19
Q

Agents to avoid with lithium

A

Thiazides
Furosemide
NSAIDs
ACE-Is

All increase lithium plasma concentrations and could cause toxicity

20
Q

Theophylline and lithium

A

lowers lithium concentration

21
Q

Neuromuscular blockers and lithium

A

lithium may prolong neuromuscular blocker effect

22
Q

Lithium and carbamazepine

A

Increase CNS toxicity
Not contraindication, but not commonly combined in practice

23
Q

Lithium and neuroleptics

A

Lithium may potentiate EPS

24
Q

Lithium and the thyroid

A

Lithium decreases synthesis and release of thyroid hormone, thus causing hypothyroidism

25
Dehydration, salt restriction, extrarenal salt loss on lithium
Increases sodium reabsorption which increases lithium plasma concentration
26
Decreased renal function and lithium
Decreased GFR and increased creatinine/BUN will increase lithium plasma concentration
27
Aging and lithium
Aging decreases GFR and increases sensitivity to ADRs. Will need to decrease lithium requirements.
28
Divalproex/Valproate for bipolar
As effective as lithium Better for rapid cycling than depressive episodes
29
Divalproex/valproate BBW
Hepatotoxicity (LFTs monitored routinely) Mitochondrial disease (increases risk for liver failure) Fetal risk Pancreatitis
30
Divalproex/valproate serum concentration
50-125 but usually target level at when achieve clinical response >80: neurotoxicity, sedation, hair loss, thrombocytopenia
31
Divalproex enteric coated to ER dosage form
Increase dose 8-20% due to less bioavailability with ER form
32
Carbamazepine for bipolar
Only for acute mania and maintenance therapy Strong inducer and autoinducer, so can take time to come to steady state
33
Lamotrigine in bipolar
Approved for maintenance therapy. Best at preventing depressive episodes compared to manic episodes Not effective in acute phase due to long titration
34
Missed lamotrigine doses
If miss >3-5 half lives (5 days), reinitiate from starting dose
35
Lamotrigine + valproic acid
increased risk for SJS rash
36
Lamotrigine rare ADRs
SJS Aseptic meningitis Hemophagocytic lymphohistiocytosis (HLH)
37
SGAs for acute bipolar treatment
All FDA approval except brexpiprazole, clozapine, iloperidone, lumateperone, lurasidone First line agents for acute mania: Aripiprazole Asenapine Cariprazine Paliperidone Quetiapine Risperidone
38
SGAs for bipolar depression
Cariprazine Quetiapine Lumateperone Lurasidone Olanzapine + fluoxetine
39
SGA for bipolar maintenance
Risperal Consta Abilify Maintena Olanzapine Quetiapine
40
Antidepressants and Bipolar
Avoid monotherapy as it can switch to manic phase (highest risk with TCA and SNRI) Avoid if symptoms of mania present
41
Type II Bipolar treatment
First-line agent = lithium, but remember takes 6-8 weeks for depressive symptom resolution Acute phase: Quetiapine, lurasidone Maintenance: lamotrigine Olanzapine + fluoxetine